Beneficial Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Use With Control-IQ Technology in Type 2 Diabetes

Affiliations

• ¹ Jaeb Center for Health Research, Tampa, FL.
• ² Division of Endocrinology, Icahn School of Medicine at Mount Sinai, New York, NY.
• ³ Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
• ⁴ Texas Diabetes and Endocrinology, Austin, TX.
• ⁵ Tandem Diabetes Care, San Diego, CA.